LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...
Researchers at Université Savoie Mont Blanc, Radboud University and the University of Oxford's Wellcome Center for ...
Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback